Stevanato Group (NYSE:STVN) Issues FY 2026 Earnings Guidance

Stevanato Group (NYSE:STVN) updated its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 0.700-0.720 for the period, compared to the consensus earnings per share estimate of 0.680. The company issued revenue guidance of $1.5 billion-$1.5 billion, compared to the consensus revenue estimate of $1.5 billion.

Analysts Set New Price Targets

A number of research firms have recently issued reports on STVN. Weiss Ratings raised shares of Stevanato Group from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, July 16th. TD Cowen raised Stevanato Group to a “strong-buy” rating in a research note on Wednesday, June 17th. Finally, Wolfe Research initiated coverage on Stevanato Group in a research report on Tuesday, June 2nd. They set an “outperform” rating and a $21.00 price objective on the stock. Two analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, Stevanato Group presently has an average rating of “Buy”.

Stevanato Group Trading Down 4.5%

STVN traded down €0.92 on Tuesday, hitting €19.67. 100,310 shares of the company were exchanged, compared to its average volume of 538,736. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.11 and a current ratio of 1.63. The firm has a fifty day simple moving average of €18.66 and a two-hundred day simple moving average of €16.97. The stock has a market capitalization of $5.96 billion, a PE ratio of 34.47, a price-to-earnings-growth ratio of 1.77 and a beta of 0.77. Stevanato Group has a 12 month low of €12.89 and a 12 month high of €28.00.

Stevanato Group (NYSE:STVN) last announced its quarterly earnings data on Tuesday, August 4th. The company reported €0.16 earnings per share for the quarter, beating the consensus estimate of €0.15 by €0.01. Stevanato Group had a return on equity of 10.27% and a net margin of 11.76%.Stevanato Group has set its FY 2026 guidance at 0.700-0.720 EPS. Sell-side analysts expect that Stevanato Group will post 0.71 earnings per share for the current year.

Insider Activity

In other Stevanato Group news, Director Madhavan Balachandran sold 1,493 shares of the stock in a transaction on Monday, June 15th. The shares were sold at an average price of €17.09, for a total transaction of €25,515.37. Following the completion of the sale, the director owned 69,458 shares of the company’s stock, valued at €1,187,037.22. This represents a 2.10% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Karen Flynn sold 1,493 shares of the firm’s stock in a transaction on Monday, June 15th. The stock was sold at an average price of €17.09, for a total transaction of €25,515.37. Following the completion of the sale, the director directly owned 5,757 shares in the company, valued at approximately €98,387.13. This trade represents a 20.59% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last 90 days, insiders sold 5,972 shares of company stock worth $102,061.

Institutional Investors Weigh In On Stevanato Group

Institutional investors and hedge funds have recently bought and sold shares of the business. T. Rowe Price Investment Management Inc. increased its stake in shares of Stevanato Group by 10.4% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 3,923,632 shares of the company’s stock valued at $78,944,000 after buying an additional 368,792 shares during the period. Bamco Inc. NY boosted its holdings in Stevanato Group by 1.4% in the fourth quarter. Bamco Inc. NY now owns 2,001,724 shares of the company’s stock valued at $40,275,000 after acquiring an additional 27,965 shares in the last quarter. Loomis Sayles & Co. L P increased its position in Stevanato Group by 2.8% during the 4th quarter. Loomis Sayles & Co. L P now owns 788,280 shares of the company’s stock valued at $15,860,000 after purchasing an additional 21,392 shares during the period. Ameriprise Financial Inc. raised its holdings in Stevanato Group by 14.2% in the 2nd quarter. Ameriprise Financial Inc. now owns 708,821 shares of the company’s stock worth $17,316,000 after purchasing an additional 87,942 shares in the last quarter. Finally, MetLife Investment Management LLC lifted its position in shares of Stevanato Group by 31.8% in the 4th quarter. MetLife Investment Management LLC now owns 650,811 shares of the company’s stock worth $13,094,000 after purchasing an additional 156,968 shares during the period.

About Stevanato Group

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.